| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |